IL-1-β decreases the expression of SERCA (sarcoplasmic reticulum calcium ATPase), and phospholamban (PLB), which can induce diastolic dysfunction, while IL-18 induces fibrosis and cardiac hypertrophy resulting in diastolic stiffness and concentric remodeling. Here, IL1B is linked to cardiac hypertrophy.